Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies (SLDAPCC)
Channelopathies, Brugada Syndrome, Long QT Syndrome
About this trial
This is an interventional supportive care trial for Channelopathies focused on measuring arrhythmias, cardiac, channelopathies, death, sudden, genetic testing, electrocardiography, ambulatory, anesthesia, local, dentistry
Eligibility Criteria
Inclusion Criteria:
- Patients with any channelopathies below, kept on optimal drug therapy, with or without ICD:
Brugada Syndrome, Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia
- Dental caries or unsatisfactory restorations in the mandible, indicating restorative dental treatment
Exclusion Criteria:
- Patients allergic to lidocaine
- Patients undergoing ICD therapy for less than three months
- Patients with recurrent syncope in the last three months
- Patients with sustained arrhythmias documented for less than 3 months
- Have received epinephrine in the last 24 hours
Sites / Locations
- Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Lidocaine with epinephrine
Lidocaine
Application of local dental anesthesia with two cartridges (3,6 mL) of lidocaine 2% with epinephrine 1:100.000 for dental restorative procedures in patients with cardiac channelopathies.
Application of local dental anesthesia with two cartridges (3,6 mL) of lidocaine 2% without vasoconstrictor for dental restorative procedures in patients with cardiac channelopathies.